Aegon Ltd. (AEG) Stock Price Today
Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.
Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...
Air Canada to launch non-stop Montréal-Seville flights in Sept 2027, expanding its European network.
Air Canada announced it will start non-stop seasonal flights between Montréal and Seville, Spain, beginning September 8, 2027. This new route is the only direct connection between North America and Seville, enhancing travel options for Canadians and ...
Air Canada launches nonstop Montreal-Seville flights starting September 2027, expanding its European network.
Air Canada will begin a new seasonal nonstop flight service between Montreal and Seville, Spain, starting September 8, 2027. This route is the only nonstop connection between North America and Seville, enhancing travel options for leisure and busines...
TSOs prioritize software investments to boost grid security and capacity amid rising demand
Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...
Bank of America misses Q3 earnings estimates due to regulatory charges and fines
Bank of America reported Q3 2026 earnings with EPS of $1.08, below the $1.10 estimate, and revenue of $30 billion, missing the $30.58 billion forecast. The earnings miss was mainly due to a regulatory settlement charge and a $1.2 billion government f...
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome
Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.
Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...
Global anthracite market to reach $16.8B by 2035, driven by steel and water filtration demand.
The global anthracite market, valued at $11.9 billion in 2025, is projected to grow to $16.8 billion by 2035 with a 3.5% CAGR. Growth is fueled by rising demand in steel production, water filtration, and advanced industrial uses due to anthracite's h...
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.
Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...
Uranium American Resources signs deal to treat abandoned mine waste at Stateline Project
Uranium American Resources has entered an agreement with DISA Uranium Corporation and State Line Mineral Ventures to treat abandoned mine waste at its Stateline Project using DISA's patented high-pressure slurry ablation technology. This deal allows ...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.